Shuling Zhang

<i>Cdkn2a</i> , the cyclin-dependent kinase inhibitor encoding p16 ^INK4a and p19 ^ARF , is a candidate for the plasmacytoma susceptibility locus, <i>Pctr1</i>

Shuling Zhang, Edward S. Ramsay, Beverly A. Mock · Proceedings of the National Academy of Sciences · 1998 · 149 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Inhibition of Notch Signaling by a γ-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats

Yixiong Chen, Shaoping Zheng, Dan Qi et al. · PLoS ONE · 2012 · 141 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

B Cell–Specific Deficiencies in mTOR Limit Humoral Immune Responses

Shuling Zhang, Margaret Pruitt, Dena Tran et al. · The Journal of Immunology · 2013 · 95 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells

Jordi Sintes, Maurizio Gentile, Shuling Zhang et al. · Nature Communications · 2017 · 64 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells

Daniel Smrž, Mi‐Sun Kim, Shuling Zhang et al. · Blood · 2011 · 53 citations · Full text

Life Sciences, Molecular Biology, Oncology +13